THE SCIENTIFIC REVIEW PROCESS

 

What is The Scientific Review?

The Concern Foundation’s biennial Scientific Review is the process that determines which researchers receive Concern’s $60,000 Conquer Cancer Now Awards, and essentially, where all the money we raise goes.

Every two years, Concern flies in top researchers from all over the world who spend a weekend in Los Angeles for a rigorous process of reviewing the best of the best research applications that have been whittled down from nearly 200 cancer research applications that were received beginning in mid-September. These finalists will receive the Conquer Cancer Now Award. Concern Foundation has funded over 700 researchers through the Conquer Cancer Now Awards.

Why Do You Need a Scientific Committee to Review to Decide Who Receives a Grant?

We believe in transparency. In order to be transparent in our grant selection and fund disbursement, we have a longstanding unbiased scientific review committee. This Scientific “Peer” Review is a process that actually has very little to do with us at Concern so that the awards are truly given to the next generation of young and innovative cancer research scientists based solely on the merits of their proposal.

SAB-Grant_infographic.png

Who is on the Scientific Review Committee?

The committee is made up of established researchers from major cancer research institutions around the world. Many of the scientific review committee scientists are prior recipients of the Conquer Cancer Now Award who have made great advances in their field and continue to sit on the committee to help fund the next big idea in cancer research.

 
David Cobrinik, M.D., Ph.D.

David Cobrinik, M.D., Ph.D.

Associate Professor of Research Ophthalmology and Biochemistry & Molecular Medicine, Cobrinik Laboratory

Children's Hospital Los Angeles

Don J. Diamond, Ph.D.

Don J. Diamond, Ph.D.

Professor, Department of Hematology & Hematopoietic Cell Transplantation

City of Hope National Medical Center

 
Sinisa Dovat, Ph.D., M.D.

Sinisa Dovat, Ph.D., M.D.

Professor of Pediatrics, Pharmacology and Biochemistry and Molecular Biology, Four Diamonds Endowed Chair, Director of Translational Research and Developmental Therapeutics

Pennsylvania State University, College of Medicine, Department of Pediatrics, Children’s Hospital Division of Pediatric Hematology/Oncology

*Anat Erdreich-Epstein, M.D., Ph.D.

*Anat Erdreich-Epstein, M.D., Ph.D.

Associate Professor of Pediatrics and Pathology

Director, USC/CHLA Summer Oncology Research Fellowship Program          

Neural Tumors Program, Basic and Translational Brain Tumor Research, Cancer and Blood Disease Institute, Division of Hematology-Oncology, Department of Pediatrics, Children's Hospital Los Angeles and Norris Comprehensive Cancer Center Keck School of Medicine, University of Southern California

 
Muller Fabbri, M.D., Ph.D.

Muller Fabbri, M.D., Ph.D.

Associate Professor, Leader Cancer Biology Program

University of Hawai’i Cancer Center

*Jennifer R. Grandis, M.D.

*Jennifer R. Grandis, M.D.

Robert K. Werbe Distinguished Professor

University of California San Francisco

 

Nora Heisterkamp Ph.d.

Professor Systems Biology

City of Hope

Steve M. Kornblau, M.D.

Steve M. Kornblau, M.D.

Professor, Departments of Leukemia and Stem Cell Transplantation & Cellular Therapy

MD Anderson Cancer Center

 
Amy S. Lee, Ph.D.

Amy S. Lee, Ph.D.

Professor of Biochemistry and Molecular Medicine

Keck School of Medicine, University of Southern California

Gangning Liang, M.D., Ph.D.

Professor of Research Urology, Director of Epigenetic Translational Research of the USC Institute of Urology

Keck School of Medicine, University of Southern California

 
Prof. Ofer Mandelboim, Ph.D

Prof. Ofer Mandelboim, Ph.D

The Concern Foundation Laboratories in the Lautenberg Center for Immunology and Cancer Research, Hebrew University, Hadassah Medical School, Jerusalem

Markus Muschen, M.D., Ph.D.

Director of the Center of Molecular and Cellular Oncology, Arthur H. and Isabel Bunker Professor of Hematology, and Professor of Immunobiology

Yale University

 

Josh Neman-Ebrahim, Ph.D.

Associate Professor of Neurological Surgery and Physiology & Neuroscience, Director for the PhD Program in Cancer Biology and Genomics

Keck School of Medicine, University of Southern California

Chintan Parekh, M.D., M.B.B.S.

Investigator; Hematology, Oncology and Blood and Marrow Transplantation, Attending Physician, Assistant Professor of Pediatrics, Keck School of Medicine of USC

Children’s Hospital Los Angeles

 

Elena Piskounova, Ph.D.

Assistant Professor of Cell Biology in Dermatology

Weill Cornell Medicine

Edward V. Prochownik, M.D., Ph.D.

*Edward V. Prochownik, M.D., Ph.D.

The Paul C. Gaffney Professor of Pediatrics and Professor of Microbiology & Molecular Genetics

Section of Hematology/Oncology, Rangos Research Center, Children's Hospital of Pittsburgh

 

Evanthia Roussos Torres, M.D., Ph.D.

Assistant Professor of Medicine

Keck School of Medicine, University of Southern California

Kathleen M. Sakamoto, M.D., Ph.D.

Kathleen M. Sakamoto, M.D., Ph.D.

Shelagh Galligan Professor of Pediatrics, Division of Hematology/Oncology

Stanford University School of Medicine

 
Prof. Eitan Yefenof, Ph.D.

Prof. Eitan Yefenof, Ph.D.

Lautenberg Center, Concern Foundation Laboratories, Hebrew University, Jerusalem


 

*Review Committee Co-chairs

Back to Top

Subscribe to our Newsletter